Thijs van Schaik

Postdoctoral Researcher at Antoni van Leeuwenhoek Ziekenhuis

Thijs is currently a at The Nederlands Cancer Institute. Previously, he was a Ph.D. candidate in molecular oncology and performed his research at the Neurosurgery department at Harvard Medical School. He set up a collaboration between the Netherlands Cancer Institute and Harvard to bring cutting-edge preclinical research techniques back to the Netherlands. In Boston, he has been involved in organizing healthcare-related events together with the Massachusetts Institute of Technology (MIT) and hospitals like Brigham and Women’s Hospital and Massachusetts General Hospital. Thijs has a BSc in neuroscience and an MSc in oncology and has been involved in research spanning from biofuel production with gene-engineered bacteria to immunotherapy for various types of cancer. His goal is to getting involved in changing outdated (corporate) systems within STEM (beta) related fields to make them 2100-proof.